Abstract: A biological information system/device/program/recording medium, which may include: a biological information measurement device; and a terminal. The biological information measurement device includes: a measurement unit that can measure first information related to a living body and second information related to the living body; a first processing unit that can execute first processing related to display or diagnosis on the first information; and a communication unit that can communicate the second information with the terminal. The terminal includes: a reception unit that can receive the second information from the biological information measurement device; a second processing unit that can execute second processing related to display or diagnosis on the second information; and a transmission unit that can transmit the second information on which the second processing is executed to the biological information measurement device.

Abstract: The present invention aims to provide a prophylactic and/or therapeutic agent for scleroderma. The present invention also aims to provide a Th2 promotion inhibitor or a vascular stabilizing agent. Glycyrrhetinic acids and/or salts thereof are applied for prevention of scleroderma, treatment of scleroderma, inhibition of Th2 promotion, or stabilization of blood vessels.